How adenovirus strives to control cellular gene expression

Virology

Volumn 363, Issue 2, 2007, Pages 357-375

  Zhao, Hongxing ^a   Granberg, Fredrik ^a   Pettersson, Ulf ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Adenovirus; Host cell gene expression; Microarray; Time course

Indexed keywords

COMPLEMENTARY DNA; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

ADENOVIRUS; APOPTOSIS; ARTICLE; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; DISEASE COURSE; DNA METABOLISM; DNA MICROARRAY; DNA REPLICATION; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GROWTH REGULATION; HOST CELL; HUMAN; HUMAN CELL; LUNG FIBROBLAST; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SYNTHESIS; VIRUS INFECTION; VIRUS REPLICATION;

ADENOVIRIDAE; ADENOVIRUS INFECTIONS, HUMAN; CELL CYCLE; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENES; GROWTH; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; VIRUS REPLICATION; WNT PROTEINS;

ADENOVIRIDAE; HUMAN ADENOVIRUS;

EID: 34248561501     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.02.013     Document Type: Article

References (77)

1. Arany Z., Newsome D., Oldread E., Livingstone D.M., and Eckner R. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374 (1995) 81-84
2. Bannister A.J., and Kouzarides T. CBP-induced stimulation of c-Fos activity is abrogated by E1A. EMBO J. 14 19 (1995) 4758-4762
3. Bayley S.T., and Mymryk J.S. Adenovirus E1A proteins and transformation. (Review). Int. J. Oncol. 5 3 (1994) 425-444
4. Bennett E.M., Bennink J.R., Yewdell J.W., and Brodsky F.M. Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. J. Immunol. 162 9 (1999) 5049-5052
5. Branton P.E., and Roopchand D.E. The role of adenovirus E4orf4 protein in viral replication and cell killing. Oncogene 20 54 (2001) 7855-7865
6. Bridge E., and Ketner G. Interaction of adenoviral E4 and E1b products in late gene expression. Virology 174 2 (1990) 345-353
7. Burgert H.G., Maryanski J.L., and Kvist S. "E3/19K" protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens. Proc. Natl. Acad. Sci. U.S.A. 84 5 (1987) 1356-1360
8. Chen M.J., Holskin B., Strickler J., Gorniak J., Clark M.A., Johnson P.J., Mitcho M., and Shalloway D. Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF. Nature 330 6148 (1987) 581-583
9. Chinnadurai G. Modulation of oncogenic transformation by the human adenovirus E1A C-terminal region. Curr. Top. Microbiol. Immunol. 273 (2004) 139-161
10. Chow L.T., Broker T.R., and Lewis J.B. Complex splicing patterns of RNAs from the early regions of adenovirus-2. J. Mol. Biol. 134 2 (1979) 265-303
11. Cobrinik D. Regulatory interactions among E2Fs and cell cycle control proteins. Curr. Top. Microbiol. Immunol. 208 (1996) 31-61
12. Cook J.L., Walker T.A., Worthen G.S., and Radke J.R. Role of the E1A Rb-binding domain in repression of the NF-kappa B-dependent defense against tumor necrosis factor-alpha. Proc. Natl. Acad. Sci. U.S.A. 99 15 (2002) 9966-9971
13. Corbin-Lickfett K.A., and Bridge E. Adenovirus E4-34kDa requires active proteasomes to promote late gene expression. Virology 315 1 (2003) 234-244
14. Coussens L.M., Yokoyama K., and Chiu R. Transforming growth factor beta 1-mediated induction of junB is selectively inhibited by expression of Ad.12-E1A. J. Cell Physiol. 160 3 (1994) 435-444
15. Cuesta R., Xi Q., and Schneider R.J. Adenovirus-specific translation by displacement of kinase Mnk1 from cap-initiation complex eIF4F. EMBO J. 19 13 (2000) 3465-3474
16. Datto M.B., Hu P.P., Kowalik T.F., Yingling J., and Wang X.F. The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B. Mol. Cell Biol. 17 4 (1997) 2030-2037
17. de Groot R.P., Kranenburg O., de Wit L., van den Eijnden-van Raaij J., Mummery C., van der Eb A.J., and Zantema A. Adenovirus E1A antagonizes both negative and positive growth signals elicited by transforming growth factor beta 1. Cell Growth Differ. 6 5 (1995) 531-540
18. Debbas M., and White E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7 4 (1993) 546-554
19. Deleu L., Shellard S., Alevizopoulos K., Amati B., and Land H. Recruitment of TRRAP required for oncogenic transformation by E1A. Oncogene 20 57 (2001) 8270-8275
20. Duerksen-Hughes P., Wold W.S., and Gooding L.R. Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor. J. Immunol. 143 12 (1989) 4193-4200
21. Enam S., Del Valle L., Lara C., Gan D.D., Ortiz-Hidalgo C., Palazzo J.P., and Khalili K. Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and beta-catenin. Cancer Res. 62 23 (2002) 7093-7101
22. Farley D.C., Brown J.L., and Leppard K.N. Activation of the early-late switch in adenovirus type 5 major late transcription unit expression by L4 gene products. J. Virol. 78 4 (2004) 1782-1791
23. Farrow S.N., White J.H., Martinou I., Raven T., Pun K.T., Grinham C.J., Martinou J.C., and Brown R. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 374 6524 (1995) 731-733
24. Fax P., Lehmkuhler O., Kuhn C., Esche H., and Brockmann D. E1A12S-mediated activation of the adenovirus type 12 E2 promoter depends on the histone acetyltransferase activity of p300/CBP. J. Biol. Chem. 275 51 (2000) 40554-40560
25. Flint J., and Shenk T. Viral transactivating proteins. Annu. Rev. Genet. 31 (1997) 177-212
26. Friedman J.M., and Horwitz M.S. Inhibition of tumor necrosis factor alpha-induced NF-kappa B activation by the adenovirus E3-10.4/14.5K complex. J. Virol. 76 11 (2002) 5515-5521
27. Fuchs M., Gerber J., Drapkin R., Sif S., Ikura T., Ogryzko V., Lane W.S., Nakatani Y., and Livingston D.M. The p400 complex is an essential E1A transformation target. Cell 106 3 (2001) 297-307
28. Fujimuro M., Wu F.Y., ApRhys C., Kajumbula H., Young D.B., Hayward G.-S., and Hayward S.D. A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat. Med. 9 3 (2003) 300-306 (Epub 2003 Feb 18)
29. Ghosh S., May M.J., and Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16 (1998) 225-260
30. Granberg F., Svensson C., Pettersson U., and Zhao H. Modulation of host cell gene expression during onset of the late phase of an adenovirus infection is focused on growth inhibition and cell architecture. Virology 343 2 (2005) 236-245
31. Granberg F., Svensson C., Pettersson U., and Zhao H. Adenovirus-induced alterations in host cell gene expression prior to the onset of viral gene expression. Virology 353 1 (2006) 1-5
32. Han J., Sabbatini P., Perez D., Rao L., Modha D., and White E. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev. 10 4 (1996) 461-477
33. Hayes B.W., Telling G.C., Myat M.M., Williams J.F., and Flint S.J. The adenovirus L4 100-kilodalton protein is necessary for efficient translation of viral late mRNA species. J. Virol. 64 6 (1990) 2732-2742
34. Iftode C., and Flint S.J. Viral DNA synthesis-dependent titration of a cellular repressor activates transcription of the human adenovirus type 2 IVa2 gene. Proc. Natl. Acad. Sci. U.S.A. 101 51 (2004) 17831-17836
35. Ishida S., Huang E., Zuzan H., Spang R., Leone G., West M., and Nevins J.R. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol. Cell. Biol. 21 14 (2001) 4684-4699
36. Jennings-Gee J.E., Tsuji Y., Pietsch E.C., Moran E., Mymryk J.S., Torti F.M., and Torti S.V. Coordinate inhibition of cytokine-mediated induction of ferritin H, manganese superoxide dismutase, and interleukin-6 by the adenovirus E1A oncogene. J. Biol. Chem. 281 24 (2006) 16428-16435
37. Johansson C., Zhao H., Bajak E., Granberg F., Pettersson U., and Svensson C. Impact of the interaction between adenovirus E1A and CtBP on host cell gene expression. Virus Res. 113 (2005) 51-63
38. Jones N. Transcriptional modulation by the adenovirus E1A gene. Curr. Top. Microbiol. Immunol. 199 Pt. 3 (1995) 59-80
39. Kannan K., Amariglio N., Rechavi G., Jakob-Hirsch J., Kela I., Kaminski N., Getz G., Domany E., and Givol D. DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene 20 18 (2001) 2225-2234
40. Kim D.H., Chang J.H., Lee K.H., Lee H.Y., and Kim S.J. Mechanism of E1A-induced transforming growth factor-beta (TGF-beta) resistance in mouse keratinocytes involves repression of TGF-beta type II receptor transcription. J. Biol. Chem. 272 1 (1997) 688-694
41. Kovesdi I., Reichel R., and Nevins J.R. Identification of a cellular transcription factor involved in E1A trans-activation. Cell 45 2 (1986) 219-228
42. Lang S.E., and Hearing P. The adenovirus E1A oncoprotein recruits the cellular TRRAP/GCN5 histone acetyltransferase complex. Oncogene 22 18 (2003) 2836-2841
43. Leek J.T., Monsen E., Dabney A.R., and Storey J.D. EDGE: extraction and analysis of differential gene expression. Bioinformatics 22 4 (2006) 507-508
44. Lesokhin A.M., Delgado-Lopez F., and Horwitz M.S. Inhibition of chemokine expression by adenovirus early region three (E3) genes. J. Virol. 76 16 (2002) 8236-8243
45. Lomonosova E., Subramanian T., and Chinnadurai G. Mitochondrial localization of p53 during adenovirus infection and regulation of its activity by E1B-19K. Oncogene 24 45 (2005) 6796-6808
46. Lowe S.W., and Ruley H.E. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7 4 (1993) 535-545
47. Missero C., Filvaroff E., and Dotto G.P. Induction of transforming growth factor beta 1 resistance by the E1A oncogene requires binding to a specific set of cellular proteins. Proc. Natl. Acad. Sci. U.S.A. 88 8 (1991) 3489-3493
48. Morrison J.A., Klingelhutz A.J., and Raab-Traub N. Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells. J. Virol. 77 22 (2003) 12276-12284
49. Muller H., Bracken A.P., Vernell R., Moroni M.C., Christians F., Grassilli E., Prosperini E., Vigo E., Oliner J.D., and Helin K. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 15 3 (2001) 267-285
50. Murakami G., Watabe T., Takaoka K., Miyazono K., and Imamura T. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol. Biol. Cell 14 7 (2003) 2809-2817
51. Nelson W.J., and Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303 5663 (2004) 1483-1487
52. Nikiforov M.A., Chandriani S., Park J., Kotenko I., Matheos D., Johnsson A., McMahon S.B., and Cole M.D. TRRAP-dependent and TRRAP-independent transcriptional activation by Myc family oncoproteins. Mol. Cell. Biol. 22 14 (2002) 5054-5063
53. Nishihara A., Hanai J., Imamura T., Miyazono K., and Kawabata M. E1A inhibits transforming growth factor-beta signaling through binding to Smad proteins. J. Biol. Chem. 274 40 (1999) 28716-28723
54. Philipson L. Adenovirus assay by the fluorescent cell counting procedure. Virology 15 (1961) 263-268
55. Pietenpol J.A., Stein R.W., Moran E., Yaciuk P., Schlegel R., Lyons R.M., Pittelkow M.R., Munger K., Howley P.M., and Moses H.L. TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61 5 (1990) 777-785
56. Polager S., Kalma Y., Berkovich E., and Ginsberg D. E2Fs up-regulate expression of genes involved in DNA replication, DNA repair and mitosis. Oncogene 21 3 (2002) 437-446
57. Querido E., Morrison M.R., Chu-Pham-Dang H., Thirlwell S.W., Boivin D., and Branton P.E. Identification of three functions of the adenovirus e4orf6 protein that mediate p53 degradation by the E4orf6-E1B55K complex. J. Virol. 75 2 (2001) 699-709
58. Routes J.M., Ryan S., Clase A., Miura T., Kuhl A., Potter T.A., and Cook J.L. Adenovirus E1A oncogene expression in tumor cells enhances killing by TNF-related apoptosis-inducing ligand (TRAIL). J. Immunol. 165 8 (2000) 4522-4527
59. Saal L.H., Troein C., Vallon-Christersson J., Gruvberger S., Borg A., and Peterson C. BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data. Genome Biol. 3 8 (2002) (SOFTWARE0003) (electronic publication)
60. Sarnow P., Hearing P., Anderson C.W., Halbert D.N., Shenk T., and Levine A.J. Adenovirus early region 1B 58,000-Dalton tumor antigen is physically associated with an early region 4 25,000-Dalton protein in productively infected cells. J. Virol. 49 3 (1984) 692-700
61. Semizarov D., Kroeger P., and Fesik S. siRNA-mediated gene silencing: a global genome view. Nucleic Acids Res. 32 13 (2004) 3836-3845
62. Shao R., Hu M.C., Zhou B.P., Lin S.Y., Chiao P.J., von Lindern R.H., Spohn B., and Hung M.C. E1A sensitizes cells to tumor necrosis factor-induced apoptosis through inhibition of IkappaB kinases and nuclear factor kappaB activities. J. Biol. Chem. 274 31 (1999) 21495-21498
63. Shapiro H.M. Flow cytometric estimation of DNA and RNA content in intact cells stained with Hoechst 33342 and pyronin Y. Cytometry 2 3 (1981) 143-150
64. Somasundaram K., and El-Deiry W.S. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region. Oncogene 14 9 (1997) 1047-1057
65. Storey J.D., Xiao W., Leek J.T., Tompkins R.G., and Davis R.W. Significance analysis of time course microarray experiments. Proc. Natl. Acad. Sci. U.S.A. 102 36 (2005) 12837-12842
66. Sturn A., Quackenbush J., and Trajanoski Z. Genesis: cluster analysis of microarray data. Bioinformatics 18 1 (2002) 207-208
67. Suomalainen M., Nakano M.Y., Boucke K., Keller S., and Greber U.F. Adenovirus-activated PKA and p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus. EMBO J. 20 6 (2001) 1310-1319
68. Wang L., Wu Q., Qiu P., Mirza A., McGuirk M., Kirschmeier P., Greene J.R., Wang Y., Pickett C.B., and Liu S. Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches. J. Biol. Chem. 276 47 (2001) 43604-43610 (Electronic publication 2001 Sep 24)
69. Wei C.L., Wu Q., Vega V.B., Chiu K.P., Ng P., Zhang T., Shahab A., Yong H.C., Fu Y., Weng Z., Liu J., Zhao X.D., Chew J.L., Lee Y.L., Kuznetsov V.A., Sung W.K., Miller L.D., Lim B., Liu E.T., Yu Q., Ng H.H., and Ruan Y. A global map of p53 transcription-factor binding sites in the human genome. Cell 124 1 (2006) 207-219
70. Vernell R., Helin K., and Muller H. Identification of target genes of the p16INK4A-pRB-E2F pathway. J. Biol. Chem. 278 46 (2003) 46124-46137
71. Verrecchia F., Chu M.L., and Mauviel A. Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J. Biol. Chem. 276 20 (2001) 17058-17062 (Electronic publication 2001 Mar 8)
72. Wold W.S., Hermiston T.W., and Tollefson A.E. Adenovirus proteins that subvert host defenses. Trends Microbiol. 2 11 (1994) 437-443
73. Wold W.S., Doronin K., Toth K., Kuppuswamy M., Lichtenstein D.L., and Tollefson A.E. Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic. Curr. Opin. Immunol. 11 4 (1999) 380-386
74. Yang Y.H., Dudoit S., Luu P., Lin D.M., Peng V., Ngai J., and Speed T.P. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30 4 (2002) e15
75. Yew P.R., Liu X., and Berk A.J. Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes Dev. 8 2 (1994) 190-202
76. Zhang Y., Chang C., Gehling D.J., Hemmati-Brivanlou A., and Derynck R. Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc. Natl. Acad. Sci. U.S.A. 98 3 (2001) 974-979
77. Zhao H., Granberg F., Elfineh L., Pettersson U., and Svensson C. Strategic attack on host cell gene expression during adenovirus infection. J. Virol. 77 20 (2003) 11006-11015